newsfilter
← Latest News
PR Newswire·

Inhibrx Reports Third Quarter 2023 Financial Results and Recent Corporate Highlights

Inhibrx, Inc. (Nasdaq: INBX), or Inhibrx, or the Company, a biopharmaceutical company with four programs in ongoing clinical trials and a strong...